These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2665969)

  • 1. Enzyme-mediated phosphorylation of polycyclic hydrocarbon metabolites: detection of non-adduct compounds in the 32P-postlabelling assay.
    Masento MS; Hewer A; Grover PL; Phillips DH
    Carcinogenesis; 1989 Aug; 10(8):1557-9. PubMed ID: 2665969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV; Smith CV; Randerath E; Randerath K
    Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study.
    Baan RA; Steenwinkel MJ; van Asten S; Roggeband R; van Delft JH
    Mutat Res; 1997 Aug; 378(1-2):41-50. PubMed ID: 9288884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunoaffinity chromatography enrichment and nuclease P1 procedures for 32P-postlabelling analysis of PAH-DNA adducts.
    Randerath K; Sriram P; Moorthy B; Aston JP; Baan RA; van den Berg PT; Booth ED; Watson WP
    Chem Biol Interact; 1998 Mar; 110(1-2):85-102. PubMed ID: 9566727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent DNA adducts formed by benzo[c]chrysene in mouse epidermis and by benzo[c]chrysene fjord-region diol epoxides reacted with DNA and polynucleotides.
    Giles AS; Seidel A; Phillips DH
    Chem Res Toxicol; 1997 Nov; 10(11):1275-84. PubMed ID: 9403182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA adduct formation in mice following treatment with used engine oil and identification of some of the major adducts by 32P-postlabelling.
    Carmichael PL; Ni Shé M; Hewer A; Jacob J; Grimmer G; Phillips DH
    Cancer Lett; 1992 Jun; 64(2):137-44. PubMed ID: 1611597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent binding of polycyclic aromatic hydrocarbon components of coal tar to DNA in mouse skin.
    Hughes NC; Pfau W; Hewer A; Jacob J; Grimmer G; Phillips DH
    Carcinogenesis; 1993 Jan; 14(1):135-44. PubMed ID: 8425262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC; Reddy MV; Randerath K
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV; Gupta RC; Randerath E; Randerath K
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 32P-postlabelling analysis of DNA adducts in humans: adduct distribution and method improvement.
    Szyfter K; Krüger J; Ericson P; Vaca C; Försti A; Hemminki K
    Mutat Res; 1994; 313(2-3):269-76. PubMed ID: 7523911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further metabolism of diol-epoxides of chrysene and dibenz[a,c]anthracene to DNA binding species as evidenced by 32P-postlabelling analysis.
    Hall M; Parker DK; Hewer AJ; Phillips DH; Grover PL
    Carcinogenesis; 1988 May; 9(5):865-8. PubMed ID: 3365849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K; Anna L; Rudnai P; Schoket B
    Mutat Res; 2011 Mar; 721(1):95-100. PubMed ID: 21237286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
    Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in detection of DNA adducts in the 32P-postlabelling assay after either 1-butanol extraction or nuclease P1 treatment.
    Gallagher JE; Jackson MA; George MH; Lewtas J; Robertson IG
    Cancer Lett; 1989 Apr; 45(1):7-12. PubMed ID: 2540901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent binding of dibenzpyrenes and benzo[a]pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin.
    Hughes NC; Phillips DH
    Carcinogenesis; 1990 Sep; 11(9):1611-9. PubMed ID: 2401051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.